New “Prime Assembly” Tool Allows Scientists to Replace Entire Genes
A breakthrough in genetic engineering could significantly expand the possibilities of gene therapy, moving beyond the simple neutralization of harmful mutations to the complete replacement of entire genes. This advancement could pave the way for treating complex genetic diseases that require more than just a minor correction.
Researchers have developed a new technology called “Prime Assembly,” which enables the insertion of long DNA segments into a genome. The method is a refinement of “prime editing,” utilizing a series of overlapping “flaps” to secure the DNA to the genome. According to the study published in the journal Nature, this approach allows for a more comprehensive restructuring of genetic material.
Bin Liu, an assistant professor of biochemistry and pharmacology at the Ohio State University College of Medicine and co-author of the study, described the process using a literary analogy. “If we consider the genome as a book, we can delete a paragraph and replace it with a new one—or even rewrite a chapter,” Liu explained. This shift represents a move toward genome assembly rather than mere gene modification.
The efficiency of this new tool is a significant leap forward. In tests conducted on mammal cells, researchers demonstrated that “Prime Assembly” could effectively insert DNA segments containing up to 11,000 base pairs. In contrast, alternative existing methods are typically only successful when inserting approximately 800 base pairs.
Beyond its capacity, the technique offers critical safety advantages. Unlike CRISPR-Cas9, which can cause double-strand breaks in DNA—a source of toxicity that may lead to cell death or widespread chromosomal loss in human T lymphocytes—Prime Assembly avoids these breaks. By reducing toxicity, the method provides a safer pathway for genomic editing.
While the results are promising, the researchers are now focused on determining the most effective vector to deliver the editor into cells. This step is essential as the team prepares to move toward in vivo trials. This update underscores the ongoing evolution of precision medicine and the potential to cure previously untreatable hereditary conditions.
For more information on this development, you can view the original report on replacing a gene in its entirety via assembly tools.
